PIRPHYTO

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated May 06, 2011, titled " Piramal Life Sciences Limited and Piramal Healthcare Limited- Demerger of the NCE Research Unit of Piramal Life Sciences Limited into Piramal Healthcare Limited."

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated September 20, 2010, titled "Piramal Life Sciences initiates Phase II Trials for P1736-05 for Type II Diabetes in India and Europe".

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated March 15, 2010, titled " Piramal Life Sciences Introduces Tinefcon, its Newly Developed Natural Remedy for Psoriasis at American Academy of Dermatology Convention in Miami, USA.". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_15032010.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated September 16, 2009, titled "Piramal Life Sciences makes Presentation on Breakthrough Molecule for Multi Drug Resistant Bacterial Infections at ICAAC Convention in the USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Pira_PR_160909.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated August 25, 2009, titled "Piramal Life Sciences completes Phase I Trials with a New Molecule for Type II Diabetes in Europe". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_25082009.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated May 20, 2009, titled "Piramal Life Sciences Limited Commences Phase I Trial on New Molecule for Diabetes - Metabolic Syndrome in Canada". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/PRAMAL_PR_20052009.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a revised press release. The date of press release should be read as May 13, 2009 instead of May 12, 2009, titled "Piramal Life Sciences receives DCGI Approval to conduct two PhaseI/II Combination Trials of P276 for Pancreatic, and Head and Neck Cancer in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramallife_PR_13052009.zip target=NEW> For more

Piramal Life Sciences Limited has informed the Exchange vide its letter dated May 13, 2009 regarding a press release dated May 12, 2009, titled "Piramal Life Sciences receives DCGI Approval to conduct two PhaseI/II Combination Trials of P276 for Pancreatic, and Head and Neck Cancer in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramalcare_PR_13052009.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a revised press release dated January 15, 2009, titled "Piramal Life Sciences initiates Phase II trials of P276 for Mantle Cell Lymphoma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/PiramalLife_PR_15012009.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated January 15, 2009, titled "Piramal Life Sciences initiates Phase II trials of P276 for Mantle Cell Lymphoma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/PIRLIFE_PR_15012009.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated October 16, 2008, titled "Piramal Life Sciences begins Phase II trial of P276 for head and neck cancer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/PiramalLife_PR_16102008.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated October 13, 2008, titled "Piramal Life Sciences receives DCGI Approval to conduct Phase I Trial of New Cancer Molecule P-1446A-05 in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_13102008.zip target=NEW> For more details click here.</a>

Piramal Life Sciences Limited has informed the Exchange regarding a press release dated September 29, 2008, titled "Piramal Life Sciences obtains approval for Initiation of Phase I Trials of New Cancer Molecule P-1446A-05 in Canada". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_29092008.zip target=NEW> For more details click here.</a>